register

News & Trends - Pharmaceuticals

World Cancer Day: Merck and MSCAN leaders dig deeper into ‘Together, we challenge those in power’

Health Industry Hub | February 5, 2024 |

Pharma News: Cancer remains the leading cause of death in Australia. With a multi-year campaign, the World Cancer Day theme is Close the Care Gap. In 2024, the focus of the theme is ‘Together, we challenge those in power’.

Meagan Walsh, Associated Medical Director of Oncology, Merck Healthcare and Tamara Dawson, CEO of MSCAN joined Health Industry Hub in reflecting on their deeply personal passion as cancer advocates.

The duo dug deeper into whether challenging those in power reflects the collective effort needed to bridge existing gaps in cancer care.

The conversation shifted to the landmark Australian Cancer Plan released in November and how each organisation contributed to its development. The discussion expanded to whether the Plan will attract the necessary policy changes and investment required to improve health inequities, especially among culturally and linguistically diverse (CALD) communities, First Nations people, and those living in remote/rural areas.

Addressing the landscape of cancer research funding, the discussion delved into Cancer Australia’s recent data which showed a three-fold increase in funding but ignored the investment from the pharmaceutical industry. Ms Walsh provided insights into how Merck is contributing to cancer research both locally and globally, emphasising the need for a holistic approach, with industry-funded research playing a crucial role.

Lastly, Ms Dawson shared MSCAN’s advocacy priorities for the year and addressed the potential impact of an early federal election on their plans.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.